Business2 outlets
Mazumdar-Shaw's Mission to Expand Access to Life-Saving Drugs
Kiran Mazumdar-Shaw, founder of Biocon and a prominent figure in India's biotechnology sector, has built the company into a multibillion-dollar enterprise specializing in insulin and biosimilar production. As Mazumdar-Shaw transitions leadership responsibilities, she is focusing on expanding access to life-saving medications globally. Biocon has grown from modest beginnings to become one of the world's largest producers in its sector.
Key takeaways
- 1.Biocon, under Mazumdar-Shaw's leadership, has achieved significant scale as a major global producer of insulin and biosimilars
- 2.Mazumdar-Shaw is transitioning leadership to successors while maintaining focus on drug accessibility initiatives
- 3.The company's mission centers on expanding access to vital medications, particularly in markets with limited drug availability
Outlet bias
Based on Trace's curated lean for each newsroom. Scroll to coverage below to rate any outlet Left / Center / Right yourself.
Left 0% · 0Center 100% · 2